Serum HE4 as a diagnostic and prognostic marker for lung cancer
Kota Iwahori(Osaka International Cancer Institute), Tetsuji Naka(Iwate Medical University), Masashi Kobayashi(Obayashi (Japan)), Yoshihiro Fujii(Nihon Institute of Medical Science), Hidekazu Suzuki(University of California San Diego), Tomonori Hirashima(Osaka Prefectural Medical Center), Yoshiro Kishi(Medical & Biological Laboratories (Japan)), Norio Okamoto(Osaka Prefectural Medical Center), Ichiro Kawase(Osaka University), Rie Uehara(Medical & Biological Laboratories (Japan))
Cited by 80
Related Papers
The paradigm of IL-6: from basic science to medicine.
|Arthritis Research|2002|481
Adiponectin Inhibits Endothelial Synthesis of Interleukin-8
|Circulation Research|2005|257
Mammalian Target of Rapamycin Pathway Regulates Insulin Signaling via Subcellular Redistribution of Insulin Receptor Substrate 1 and Integrates Nutritional Signals and Metabolic Signals of Insulin
|Molecular and Cellular Biology|2001|250
Serum leucine-rich alpha-2 glycoprotein is a disease activity biomarker in ulcerative colitis
|Inflammatory Bowel Diseases|2012|230